CDK9 anticorps (N-Term)

N° du produit ABIN926890

Cet anticorps Lapin Polyclonal détecte spécifiquement CDK9 dans WB. Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour CDK9 anticorps (N-Term) (ABIN926890)

Antigène: CDK9 (Cyclin-Dependent Kinase 9 (CDK9))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CDK9 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-CDK9 anticorps

Épitope: N-Term

Purification: Purified

Immunogène: CDK9 antibody was raised in rabbit using the N terminal of CDK9 as the immunogen

Information d'application

Indications d'application: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur CDK9

Antigène: CDK9 (Cyclin-Dependent Kinase 9 (CDK9))

Autre désignation: CDK9

Sujet: CDK9 is the member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to production elongation by phosphorylating the CTD of the large subunit of RNA polymerase II (RNAP II), SUPT5H and RDBP. The CDK9/cyclin-K complex has also a kinase activity toward CTD of RNAP II and can substitute for P-TEFb in vitro. Synonyms: Polyclonal CDK9 antibody, Anti-CDK9 antibody, cyclin-dependent kinase 9 antibody, C-2k antibody, CDC2L4 antibody, PITALRE antibody, TAK antibody.

Pathways: Cycle Cellulaire